Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia
A recent multicentre placebo-controlled trial by Rolnick et al. has indicated that taking 150 mg aspirin daily in women at high risk of pre-eclampsia reduced the incidence of the disease from 4.3% to 1.5% in comparison with placebo. Although the findings of this study are important, a high proportion of women withdrew their consent and not all safety outcomes have been reported. This journal watch article discusses the paper in more detail.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Obstetric medicine - 11(2018), 2 vom: 16. Juni, Seite 90-91 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Story, Lisa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 01.10.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1177/1753495X18775898 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM286401797 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM286401797 | ||
| 003 | DE-627 | ||
| 005 | 20231225051626.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/1753495X18775898 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0954.xml |
| 035 | |a (DE-627)NLM286401797 | ||
| 035 | |a (NLM)29997692 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Story, Lisa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.10.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a A recent multicentre placebo-controlled trial by Rolnick et al. has indicated that taking 150 mg aspirin daily in women at high risk of pre-eclampsia reduced the incidence of the disease from 4.3% to 1.5% in comparison with placebo. Although the findings of this study are important, a high proportion of women withdrew their consent and not all safety outcomes have been reported. This journal watch article discusses the paper in more detail | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Aspirin | |
| 650 | 4 | |a pre-eclampsia | |
| 700 | 1 | |a Nelson-Piercy, Catherine |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Obstetric medicine |d 2008 |g 11(2018), 2 vom: 16. Juni, Seite 90-91 |w (DE-627)NLM253587972 |x 1753-495X |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2018 |g number:2 |g day:16 |g month:06 |g pages:90-91 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/1753495X18775898 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2018 |e 2 |b 16 |c 06 |h 90-91 | ||